Remaining TC-5214 Phase III efficacy studies do not meet endpoint, regulatory filing will not be pursued
20 March 2012 | By AstraZeneca
Top-line results from the remaining Phase III studies - announced...
List view / Grid view
News
Merck and Safe Water Network launch Initiative
20 March 2012 | By Merck
Collaboration advances Merck's commitment to fighting disease to help the world be well...
Pradaxa® (dabigatran etexilate) receives final NICE recommendation for stroke prevention in atrial fibrillation in the UK
19 March 2012 | By NICE
Pradaxa® must now be made available for use by the UK National Health Service (NHS)...
FDA approves first Boniva generics to treat or prevent osteoporosis
19 March 2012 | By FDA
The U.S. FDA approved the first generic versions of Boniva (ibandronate) tablets...
Merck and partners create the California Institute for Biomedical Research (Calibr)
19 March 2012 | By Merck
Calibr presents a new paradigm for academic-industry cooperation...
Abbott announces patient enrollment in two phase 3 studies of HUMIRA® (adalimumab)
Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA® (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa (HS).
Results from phase 3 trial of TAK-085 for the treatment of Hyperlipidemia
19 March 2012 | By Takeda Pharmaceutical Company Limited
Results presented at 76th Annual Scientific Meeting of the Japanese Circulation Society in Fukuoka...
Pfizer pledges to strengthen lifelong health strategies for Asia-Pacific region
18 March 2012 | By Pfizer
Experts on ageing highlight importance of health as driver of economic growth...
Alcon gains exclusive ex-US rights for ocriplasmin
16 March 2012 | By Novartis
Potential first pharmacological treatment for symptomatic vitreomacular adhesion...
Sanofi to acquire Pluromed, Inc., expanding its presence in biosurgery
16 March 2012 | By Sanofi
Sanofi and Pluromed Inc. have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc...
GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands
15 March 2012 | By GlaxoSmithKline
Agreement reached to divest brands in Europe to Omega Pharma for €470m (£391m)...
Switching to “simply paperless” particle counting from MET ONE saves you time immediately
14 March 2012 | By HACH LANGE
Modern pharmaceutical injectable drug production is heavily regulated...
Roche receives request for additional information from the Federal Trade Commission
13 March 2012 | By Roche
The 2nd request seeks additional information regarding Roche’s microarray business...
Syrris invites scientists to benefit from free flow and automated process chemistry workshops
13 March 2012 | By kdm communications limited
Laboratory scale chemists offered educational workshops and seminars...
AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity
13 March 2012 | By AstraZeneca
AstraZeneca will vigorously defend its legal rights...
